← FDA DRUG APPROVALS

FDA ANDA · ANDA070975

CLONIDINE HYDROCHLORIDE

Sponsor: ACTAVIS ELIZABETH

APPLICATION
ANDA070975
TYPE
ANDA
ORIGINAL APPROVAL
1986-12-16
LATEST ACTION
2013-01-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CLONIDINE HYDROCHLORIDEPrescription
CLONIDINE HYDROCHLORIDE 0.2MG · TABLET · ORAL

Approval history

2013-01-16Labeling · Supplement 41 · standardAP
2010-06-23Labeling · Supplement 35AP
2002-08-08Manufacturing (CMC) · Supplement 17AP
2002-06-25Manufacturing (CMC) · Supplement 16AP
2002-06-25Manufacturing (CMC) · Supplement 15AP
2001-11-02Manufacturing (CMC) · Supplement 14AP
2000-03-20Manufacturing (CMC) · Supplement 12AP
2000-03-20Manufacturing (CMC) · Supplement 13AP
1999-09-23Manufacturing (CMC) · Supplement 11AP
1997-02-18Labeling · Supplement 10AP
1996-01-18Manufacturing (CMC) · Supplement 8AP
1992-02-04Manufacturing (CMC) · Supplement 7AP
1989-10-13Labeling · Supplement 6AP
1988-11-17Labeling · Supplement 5AP
1988-05-10Labeling · Supplement 4AP
1988-01-28Manufacturing (CMC) · Supplement 3AP
1987-06-09Manufacturing (CMC) · Supplement 2AP
1987-06-09Manufacturing (CMC) · Supplement 1AP
1986-12-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →